Taiwan FDA registration cf4c6fe359ea47d046c7a89c3899e8a7
SEBIA CAPI 3 CDT (Non-Sterile)
TW: 賽比亞 第三代毛細管缺醣攜鐵蛋白檢測試劑(未滅菌)
Taiwan·Risk Class 1·MD·SEBIA·Registered Jan 18, 2021 – Jan 18, 2026ExpiredRegistration details
- Analysis ID
- cf4c6fe359ea47d046c7a89c3899e8a7
- License Form
- Ministry of Health Medical Device Import No. 022251
- Customs Code
- DHA09402225107
Company information
- Manufacturer
- SEBIA
- Manufacturer Country
- France
- Authorized Representative
- ARQon Medtech Co., Ltd.
Product details
- Intended Use
- Limited to the first level identification range of the measures for the administration of medical devices "r-glutamyl transferase (GGT) and isoenzyme test system (A.1360)".
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1360 r-glutamyl transferase (GGT) and isoenzyme test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 18, 2021
- Expiry Date
- Jan 18, 2026
About this record
Access comprehensive regulatory information for SEBIA CAPI 3 CDT (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number cf4c6fe359ea47d046c7a89c3899e8a7 and manufactured by SEBIA. The authorized representative in Taiwan is ARQon Medtech Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices